These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
667 related items for PubMed ID: 33408116
1. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling. Yamada K, Hori Y, Inoue S, Yamamoto Y, Iso K, Kamiyama H, Yamaguchi A, Kimura T, Uesugi M, Ito J, Matsuki M, Nakamoto K, Harada H, Yoneda N, Takemura A, Kushida I, Wakayama N, Kubara K, Kato Y, Semba T, Yokoi A, Matsukura M, Odagami T, Iwata M, Tsuruoka A, Uenaka T, Matsui J, Matsushima T, Nomoto K, Kouji H, Owa T, Funahashi Y, Ozawa Y. Cancer Res; 2021 Feb 15; 81(4):1052-1062. PubMed ID: 33408116 [Abstract] [Full Text] [Related]
2. NF-κB suppression synergizes with E7386, an inhibitor of CBP/β-catenin interaction, to block proliferation of patient-derived colon cancer spheroids. Kanda Y, Ohata H, Miyazaki T, Sakai H, Mori Y, Shiokawa D, Yokoi A, Owa T, Ochiai A, Okamoto K. Biochem Biophys Res Commun; 2022 Jan 01; 586():93-99. PubMed ID: 34837838 [Abstract] [Full Text] [Related]
3. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F, Shang S, Yang YW, Zhang HZ, Xu TL, Yu JJ, Zhou DD, Cui B, Li K, Lv XX, Zhang XW, Liu SS, Yu JM, Wang F, Zhang C, Huang B, Hu ZW. Gastroenterology; 2019 Feb 01; 156(3):708-721.e15. PubMed ID: 30365932 [Abstract] [Full Text] [Related]
4. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia. Gang EJ, Hsieh YT, Pham J, Zhao Y, Nguyen C, Huantes S, Park E, Naing K, Klemm L, Swaminathan S, Conway EM, Pelus LM, Crispino J, Mullighan CG, McMillan M, Müschen M, Kahn M, Kim YM. Oncogene; 2014 Apr 24; 33(17):2169-78. PubMed ID: 23728349 [Abstract] [Full Text] [Related]
5. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway. Wei LH, Lin JM, Chu JF, Chen HW, Li QY, Peng J. Chin J Integr Med; 2017 Nov 24; 23(11):858-863. PubMed ID: 29080197 [Abstract] [Full Text] [Related]
17. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin. Freeman TJ, Smith JJ, Chen X, Washington MK, Roland JT, Means AL, Eschrich SA, Yeatman TJ, Deane NG, Beauchamp RD. Gastroenterology; 2012 Mar 12; 142(3):562-571.e2. PubMed ID: 22115830 [Abstract] [Full Text] [Related]
18. RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade. Ganesh S, Shui X, Craig KP, Park J, Wang W, Brown BD, Abrams MT. Mol Ther; 2018 Nov 07; 26(11):2567-2579. PubMed ID: 30274786 [Abstract] [Full Text] [Related]
19. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling. Ye Q, Yao G, Zhang M, Guo G, Hu Y, Jiang J, Cheng L, Shi J, Li H, Zhang Y, Liu H. Carcinogenesis; 2015 Mar 07; 36(3):318-26. PubMed ID: 25600769 [Abstract] [Full Text] [Related]
20. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE. Breast Cancer Res; 2007 Mar 07; 9(5):R63. PubMed ID: 17897439 [Abstract] [Full Text] [Related] Page: [Next] [New Search]